Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Mallinckrodt
US Department of Justice
Citi
Farmers Insurance
US Army
Boehringer Ingelheim
Merck
Cipla

Generated: May 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020457

« Back to Dashboard

NDA 020457 describes ETOPOPHOS PRESERVATIVE FREE, which is a drug marketed by Bristol Myers Squibb and is included in two NDAs. It is available from one supplier. Additional details are available on the ETOPOPHOS PRESERVATIVE FREE profile page.

The generic ingredient in ETOPOPHOS PRESERVATIVE FREE is etoposide phosphate. There are eleven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the etoposide phosphate profile page.
Summary for 020457
Tradename:ETOPOPHOS PRESERVATIVE FREE
Applicant:Bristol Myers Squibb
Ingredient:etoposide phosphate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 020457
Mechanism of ActionTopoisomerase Inhibitors
Suppliers and Packaging for NDA: 020457
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ETOPOPHOS PRESERVATIVE FREE etoposide phosphate INJECTABLE;INJECTION 020457 NDA E.R. Squibb & Sons, L.L.C. 0015-3404 N 0015-3404-20

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 100MG BASE/VIAL
Approval Date:May 17, 1996TE:RLD:Yes

Expired US Patents for NDA 020457

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bristol Myers Squibb ETOPOPHOS PRESERVATIVE FREE etoposide phosphate INJECTABLE;INJECTION 020457-001 May 17, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Bristol Myers Squibb ETOPOPHOS PRESERVATIVE FREE etoposide phosphate INJECTABLE;INJECTION 020457-001 May 17, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Cantor Fitzgerald
Fish and Richardson
AstraZeneca
Baxter
Fuji
Deloitte
Mallinckrodt
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.